CD22, an inhibitory co-receptor of the B-cell receptor, has been identified as a potential candidate gene for the development of autoimmune hemolytic anemia in mice. In this study, we have examined Cd22(tm1Msn) CD22-deficient mice and identified an increase in red blood cell (RBC) turnover and stress erythropoiesis, which might be consistent with hemolysis. We then, however, eliminated CD22-deficiency as the cause of accelerated RBC turnover and established that enhanced RBC turnover occurs independently of B cells and anti-RBC autoantibodies. Accelerated RBC turnover in this particular strain of CD22-deficient mice is red cell intrinsic and appears to be the consequence of a defective allele of glucose phosphate isomerase, Gpi1(c) . This form of Gpi1 was originally derived from wild mice and results in a substantial reduction in enzyme activity. We have identified the polymorphism that causes impaired catalytic activity in the Gpi1(c) allele, and biochemically confirmed an approximate 75% reduction of GPI1 activity in Cd22(-/-) RBCs. The Cd22(-/-) .Gpi1(c) congenic mouse provides a novel animal model of GPI1-deficiency, which is one of the most common causes of chronic non-spherocytic hemolytic anemia in humans.
- glucose-6-phosphate isomerase